Back to Search
Start Over
Prediabetes versus type 2 diabetes in patients with acute myocardial infarction and current smoking.
- Source :
-
The American journal of the medical sciences [Am J Med Sci] 2022 Nov; Vol. 364 (5), pp. 612-623. Date of Electronic Publication: 2022 May 17. - Publication Year :
- 2022
-
Abstract
- Background: Smoking is linked with increased risk of cardiovascular events among diabetic patients. Prediabetes is associated with increased risk for microvascular and macrovascular complications. We compared the 2-year clinical outcomes of current smoking between prediabetic and type 2 diabetes mellitus (T2DM) patients with acute myocardial infarction (AMI) after newer-generation drug-eluting stent (DES) implantation.<br />Methods: A total of 5161 AMI patients who were currently smoking were classified into normoglycemia (group A: 1,416), prediabetes (group B: 1,740), and T2DM (group C: 2,005) groups. The primary endpoint was major adverse cardiac events (MACEs), defined as all-cause death, recurrent myocardial infarction and any repeat revascularization. The secondary endpoint was the occurrence of stent thrombosis (ST) and stroke.<br />Results: The cumulative incidences of all primary and secondary endpoints including MACEs (adjusted hazard ratio [aHR]: 1.150; 95% confidence interval [CI]: 0.891-1.484; P = 0.284), ST, and stroke were similar between group B and group C. The cumulative incidences of MACEs (aHR: 1.385; 95% CI: 1.007-1.904; P = 0.045) and all-cause death or MI were significantly higher in group B than in group A. The cumulative incidences of MACEs (aHR: 1.572; 95% CI: 1.157-2.137; P = 0.004), all-cause death, Re-MI, and all-cause death or MI were significantly higher in group C than in group A.<br />Conclusions: Current smoking leads to worse clinical outcomes in patients with AMI and prediabetes, and thus, similarly to T2DM patients, more attention and more intensive treatment strategy including quitting smoking would be advantageous.<br />Competing Interests: Conflict of Interest Statement The authors have no financial or other conflicts of interest to disclose.<br /> (Copyright © 2022 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Humans
Smoking adverse effects
Smoking epidemiology
Treatment Outcome
Drug-Eluting Stents adverse effects
Prediabetic State complications
Prediabetic State epidemiology
Percutaneous Coronary Intervention adverse effects
Diabetes Mellitus, Type 2 complications
Diabetes Mellitus, Type 2 epidemiology
Myocardial Infarction complications
Thrombosis complications
Stroke etiology
Subjects
Details
- Language :
- English
- ISSN :
- 1538-2990
- Volume :
- 364
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- The American journal of the medical sciences
- Publication Type :
- Academic Journal
- Accession number :
- 35595078
- Full Text :
- https://doi.org/10.1016/j.amjms.2022.05.016